Skip to content
Disclosery

EXANE DERIVATIVES: CVX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CVX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 14,857 CVX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 14,857 shares
    Change vs previous 13F -3,876 shares

    1.24% of the 13F portfolio, value $2,150,522.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 18,733 shares
    Change vs previous 13F -2,146 shares

    0.86% of the 13F portfolio, value $3,050,065.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 20,879 shares
    Change vs previous 13F +20,042 shares

    0.6% of the 13F portfolio, value $2,450,028.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 837 shares
    Change vs previous 13F -12,017 shares

    0.02% of the 13F portfolio, value $84,909.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 12,854 shares
    Change vs previous 13F +9,539 shares

    0.31% of the 13F portfolio, value $1,335,875.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,315 shares
    Change vs previous 13F -496 shares

    0.1% of the 13F portfolio, value $347,358.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,811 shares
    Change vs previous 13F -14,979 shares

    0.1% of the 13F portfolio, value $321,819.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 18,790 shares
    Change vs previous 13F not available

    0.44% of the 13F portfolio, value $1,352,824.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).